ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2037

Rheumatic Manifestations May be the First Clinical Presentation of Arterial Calcification Due to CD73 Deficiency

Kam Newman1, megha Sawhney2, James D. Katz3, richard siegel4, alessandra brofferio5 and Manfred Boehm6, 1national institutes of arthritis, musculoskeletal, and skin disease, National Institutes of Health, Bethesda, MD, 2national institutes of health, Bethesda, MD, 3Department of Medicine, Division of Rheumatology, The George Washington University, Washington, DC, 4National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, 5national institutes of health, Bethesda,, MD, 6Laboratory of Cardiovascular Regenerative Medicine, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: calcinosis, degenerative arthritis and polyarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Miscellaneous Rheumatic and Inflammatory Diseases Oral Session II

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose:   ACDC is a hereditary ectopic
mineralization syndrome caused by mutations in the NT5E gene that encodes
CD73.  CD73 is a membrane bound 5′ ecto-nucleotidase that hydrolyzes 5’AMP into
adenosine and inorganic phosphate.  This autosomal recessive disease clinically
manifests with extensive mineralization of arteries predominantly of the lower
extremities.  Claudication and arthralgia complaints are prominent among
affected individuals.  The anatomic distribution of some of the calcifications
in ACDC could be due to a tissue-specific differential of adenosine receptor
levels on different cell types, which could apply to not just vessels but the
joint capsule as well.  The focus of our study is to characterize the rheumatic
manifestations of patients with ACDC.

Methods:   Six individuals with
genetically confirmed disease where assessed clinically, radiologically, immunologically
and biochemically.  Demographics and complete history and physicals were
catalogued.

Results:    Four out of 6 patients were
female (Table 1).  The mean age at onset of symptoms was 16.7 years.  In 5 out
of 6 individuals, the initial clinical presentation was arthralgia/arthritis
and hence the first specialist seen was a rheumatologist.  In the 6th instance,
the initial presenting complaint was claudication hence culminating in
evaluation by a vascular surgeon.  The most common pattern of arthritis was a
symmetric, additive, small joint arthritis that in most cases was diagnosed as
rheumatoid arthritis at initial presentation.  The most common joints affected
included PIPs and MCPs including reports of pain, stiffness, swelling and
erythema.  Episodic flares lasting up to ten days were reported by all subjects
and these were responsive to either NSAIDs or short-term corticosteroids.  Plain
radiography demonstrates joint space loss, capsular calcification, heterotopic
bone formation, homogeneous areas of soft tissue calcification and degenerative
changes reminiscent of erosive osteoarthritis (image 1).  Carpal erosions and
meniscal calcifications were not a feature of the disease.  All patients were
ANA negative.

Conclusion:   This is the first study to
characterize the rheumatic manifestations of ACDC patients.  A mixed
degenerative-erosive radiological pattern is highlighted.  Rheumatologists may
be the first specialists to encounter these individuals and the presenting
symptoms may be confused with rheumatoid arthritis. 

Table 1. Clinical
characteristics of the patients

Clinical

Characteristic

 

Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

Patient 6

Age

55

60

50

59

57

49

Sex

F

F

F

M

M

F

Age at onset

18

16

16

17

17

16

Age of first joint involvement

18

16

16

16

17

35

Initial presentation

Arthralgia, arthritis

Arthralgia, arthritis

Arthralgia, arthritis

Arthralgia, arthritis

Arthralgia, arthritis

Intermittent claudication

Type of joint involvement

Polyarthralgia, stiffness, swelling, erythema

Polyarthralgia, stiffness, swelling, erythema

Polyarthralgia, stiffness, swelling, erythema

Polyarthralgia, stiffness, swelling, erythema

Polyarthralgia, stiffness, swelling, erythema

Polyarthralgia, stiffness, swelling, erythema

First specialist seen

PMD, sent to rheumatologist for RA

PMD, sent to rheumatologist for RA

PMD, sent to rheumatologist for RA

PMD, sent to rheumatologist for RA

PMD, sent to rheumatologist

PMD, sent to cardiovascular surgeon

Type of pain

Inflammatory

Inflammatory

Inflammatory

Inflammatory

Inflammatory

Inflammatory

Type of involved joints

Small

Small

Small

Medium

Small

Small

First involved joints

PIP

PIP, MCP

PIP, MCP,   MTP

Right elbow

PIP, MCP

PIP, MCP, CMP

 

Symmetric

Y

Y

Y

Y

Y

Y

Additive arthritis

Y

Y

Y

Y

Y

Y

Flares

Y

Y

Y

Y

Y

Y

Duration of each flare

7-10 days

7-10 days

7-10 days

7-10 days

7-10 days

7-10 days

Response to NSAIDs

Aborts the flare

Aborts the flare

Aborts the flare

Aborts the flare

Aborts the flare

Aborts the flare

ANA

N

N

N

N

N

N

RF

N

N

N

N

N

N

Anti-CCP

N

N

N

N

N

N

Figure
1. Moderate degenerative changes of distal third DIP with subluxation
and swan-neck deformity


Disclosure: K. Newman, None; M. Sawhney, None; J. D. Katz, None; R. siegel, None; A. brofferio, None; M. Boehm, None.

To cite this abstract in AMA style:

Newman K, Sawhney M, Katz JD, siegel R, brofferio A, Boehm M. Rheumatic Manifestations May be the First Clinical Presentation of Arterial Calcification Due to CD73 Deficiency [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/rheumatic-manifestations-may-be-the-first-clinical-presentation-of-arterial-calcification-due-to-cd73-deficiency/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatic-manifestations-may-be-the-first-clinical-presentation-of-arterial-calcification-due-to-cd73-deficiency/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology